Aldeyra Therapeutics, Inc. (NASDAQ:ALDX - Get Free Report) Director Richard Douglas bought 200,000 shares of Aldeyra Therapeutics stock in a transaction on Wednesday, November 11th. The stock was purchased at an average price of $0.64 per share, with a total value of $128,000.00. Following the completion of the acquisition, the director directly owned 395,000 shares of the company's stock, valued at $252,800. This represents a 102.56% increase i…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.